Reckitt Benckiser strikes deal for BMS drugs in Latam
LONDON Feb 12 (Reuters) - Reckitt Benckiser said on Tuesday it had struck a three-year collaboration deal with Bristol-Myers Squibb for a number of over-the-counter remedies in Brazil, Mexico and other parts of Latin America.
The British consumer goods group, which will pay Bristol an initial $482 million, has an option to purchase the brands from the U.S. drugmaker at the end of the three-year period.
- U.S. war veteran released by North Korea returns home |
- Pennsylvania newlyweds "just wanted to murder someone together:" police
- Ice storm causes blackouts, delays in Texas, Arkansas
- WTO overcomes last minute hitch to reach its first global trade deal
- China's parliament: Japan has "no right to criticize" air defense zone